2026 Autoimmune Neurology Conference | C18 - Neurosarcoidosis
| 02:45 PM - 03:12 PM CDT | Speaker |
Diagnosis and Misdiagnosis
Giovanna Manzano, MD |
| 03:12 PM - 03:39 PM CDT | Speaker |
Pathophysiology and Emerging Biomarkers
Carlos A. Pardo-Villamizar, MD |
| 03:39 PM - 04:06 PM CDT | Speaker |
Approach to Treatment
Spencer Hutto, MD |
| 04:06 PM - 04:16 PM CDT | Speaker |
Abstract Presentation #1
|
| 04:16 PM - 04:26 PM CDT | Speaker |
Abstract Presentation #2
|
| Yoji Hoshina, MD | Dr. Hoshina has nothing to disclose. |
| Jeffrey Shen | Jeffrey Shen has nothing to disclose. |
| Avi Singh Gandh, MD | Dr. Gandh has nothing to disclose. |
| Allen J. Aksamit, Jr., MD, FAAN | Dr. Aksamit has nothing to disclose. |
| Giovanna Manzano, MD | Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx. |
| Danielle Pitter, MD | Dr. Pitter has nothing to disclose. |
| Andrea Mendez Colmenares, MD, PhD | Dr. Mendez Colmenares has nothing to disclose. |
| Carlos A. Pardo-Villamizar, MD | The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| Conor Kelly, MD | Dr. Kelly has nothing to disclose. |
| Denis T. Balaban, MD | Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infucare. Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedLive. The institution of Dr. Balaban has received research support from ArgenX. |
| Bruna Leles Vieira de Souza, MD | Miss Leles Vieira de Souza has nothing to disclose. |
| Joao Vitor Mahler, MD | Dr. Mahler has received research support from The Sumaira Foundation. |
| Elijah Lackey, MD | Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lackey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Doximity. |
| Spencer Hutto, MD | Dr. Hutto has nothing to disclose. |
| Michelle M. Maher, MD | Dr. Maher has nothing to disclose. |
| Shruti P. Agnihotri, MD | An immediate family member of Dr. Agnihotri has or had stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech. |
| Stacey Clardy, MD, PhD, FAAN | Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed. |
| Zachery Rohm, MD | Dr. Rohm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rohm has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Rohm has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for City of Chicago. |
| Ashley T. Lisbeth, PA | Ms. Lengel has nothing to disclose. |
| Jeffrey M. Gelfand, MD, MS, FAAN | Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities. |